RODRIGO CAMACHO: Open Payments
NPI 1053466276 · HOT SPRINGS, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,416 in 64 payments from 18 companies in 2025. Trend: 2023 $1,245 · 2024 $1,533 · 2025 $1,416
Food & beverage: $1,416
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $222 |
| Ipsen Biopharmaceuticals, Inc | 5 | $202 |
| Gilead Sciences, Inc. | 7 | $197 |
| Regeneron Healthcare Solutions, Inc. | 6 | $157 |
| Lilly USA, LLC | 7 | $120 |
| Aimmune Therapeutics, Inc. | 6 | $110 |
| Janssen Scientific Affairs, LLC | 1 | $63 |
| Braintree Laboratories, Inc. | 4 | $58 |
| TELA Bio, Inc. | 1 | $51 |
| Ardelyx, Inc. | 2 | $43 |
Products named: IQIRVO, DUPIXENT, RINVOQ, OMVOH, ZENPEP, TREMFYA, LINZESS, OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex).
Industry payments across AR — which companies pay providers there.
